Interaction of caffeine with regadenoson-induced hyperemic myocardial blood flow as measured by positron emission tomography: a randomized, double-blind, placebo-controlled crossover trial.
Gaemperli
Oliver
O
Schepis
Tiziano
T
Koepfli
Pascal
P
Siegrist
Patrick T
PT
Fleischman
Samuel
S
Nguyen
Patricia
P
Olmsted
Ann
A
Wang
Whedy
W
Lieu
Hsiao
H
Kaufmann
Philipp A
PA
D058908:Adenosine A2 Receptor Agonists; D058917:Adenosine A2 Receptor Antagonists; D002110:Caffeine / Q000494:pharmacology*; D003326:Coronary Circulation / Q000187:drug effects*; D018592:Cross-Over Studies; D004311:Double-Blind Method; D004347:Drug Interactions; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D049268:Positron-Emission Tomography; D011687:Purines / Q000494:pharmacology*; D011720:Pyrazoles / Q000494:pharmacology*; D014665:Vasodilator Agents / Q000494:pharmacology*
D058908:Adenosine A2 Receptor Agonists; D058917:Adenosine A2 Receptor Antagonists; D011687:Purines; D011720:Pyrazoles; D014665:Vasodilator Agents; C430916:regadenoson; D002110:Caffeine